Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2020-05-14 2020-05-14
Drug Identification Number 02248570 02248570
Brand name ACT RANITIDINE ACT RANITIDINE
Common or Proper name RANITIDINE 150MG TAB RANITIDINE 150MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients RANITIDINE RANITIDINE
Strength(s) 150MG 150MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 Bot, 60 U/D, 100, 500 60 Bot, 60 U/D, 100, 500
ATC code A02BA A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-05-08 2020-05-08
Actual discontinuation date 2020-05-08 2020-05-08
Remaining supply date 2020-05-08 2020-05-08
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments